Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc.
WKN: A1XCY0 / Symbol: RARE / Name: Ultragenyx / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
16,80 €
-41,67 %
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Wells Fargo & Company from $65.00 to $45.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Robert W. Baird from $72.00 to $47.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Leerink Partners from $80.00 to $70.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat
Neueste Beiträge
SVB_Leerink_LLC in Ultragenyx Pharmaceutical Inc. diskutieren